• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT / ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC. XS BRK NEEDLE; TROCAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT / ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC. XS BRK NEEDLE; TROCAR Back to Search Results
Model Number ABBOTT 98CM XS BKR NEEDLE
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
It was reported that during an irreversible electroporation ablation procedure using a sheath they temporarily loss left atrium access.The sheath was used for the transseptal puncture.When removing the dilator from the sheath a lot of force was required to remove the dilator which resulted in the loss of access.The procedure was completed using the original device with no patient complications.This report reflects information received by fda in the form of a notification per 803.22 (b)(2).Reference report mw5148841.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XS BRK NEEDLE
Type of Device
TROCAR
Manufacturer (Section D)
ABBOTT / ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC.
MDR Report Key18274166
MDR Text Key330002190
Report NumberMW5148840
Device Sequence Number1
Product Code DRC
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 10/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model NumberABBOTT 98CM XS BKR NEEDLE
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/05/2023
Patient Sequence Number1
-
-